Overview


According to FutureWise analysis the market for vietnam plasma fractionation in 2023 is US$ 70.19 million, and is expected to reach US$ 107.89 million by 2031 at a CAGR of 5.5%.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Vietnam Plasma Fractionation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Vietnam Plasma Fractionation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • BAXTER INTERNATIONAL INC.
  • BIOTEST AG
  • BIO PRODUCTS LABORATORY LTD.
  • GETZ HEALTHCARE
  • GRIFOLS SA
  • KEDRION BIOPHARMA
  • OCTAPHARMA
  • NOVO NORDISK
  • SANOVA HEALTHCARE
  • SANQUIN BLOOD SUPPLY FOUNDATION
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Albumin
  • Immunoglobulins
  • Subcutaneous Immunoglobulin (SCIG)
  • Intravenous Immunoglobulin (IVIG)
  • Coagulation Factor VIII
  • Coagulation Factor IX

By Application

  • Neurology
  • Hematology
  • Immunology
  • Critical Care
  • Others

By End User

  • Hospitals
  • Clinical Research Laboratories

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Vietnam Plasma Fractionation Market By Product, By Application and By End User.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— Vietnam
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Vietnam Plasma Fractionation Market Variables, Trends and Scope

    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Vietnam Plasma Fractionation Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Vietnam Plasma Fractionation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Vietnam Plasma Fractionation Market, By Product Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Albumin
        2. Immunoglobulins
        3. Subcutaneous Immunoglobulin (SCIG)
        4. Intravenous Immunoglobulin (IVIG)
        5. Coagulation Factor VIII
        6. Coagulation Factor IX

  • 8.   Vietnam Plasma Fractionation Market, By Application Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Neurology
        2. Hematology
        3. Immunology
        4. Critical Care
        5. Others

  • 9.   Vietnam Plasma Fractionation Market, By End User Historical Analysis and Forecast 2025-2033 (USD Million)

    •   1. Hospitals
        2. Clinical Research Laboratories

  • 10.   Market Share Analysis and Competitive Landscape

    •   1. Vietnam Landscape - Key Players, Revenue and Presence
        2. Vietnam Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Vietnam Emerging Companies
        4. Vietnam- Market Share Analysis and Key Regional Players
        5. Vietnam Key Player - Growth Matrix

  • 11.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. BAXTER INTERNATIONAL INC.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. BIOTEST AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. BIO PRODUCTS LABORATORY LTD.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GETZ HEALTHCARE
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GRIFOLS SA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. KEDRION BIOPHARMA
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. OCTAPHARMA
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. NOVO NORDISK
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. SANOVA HEALTHCARE
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. SANQUIN BLOOD SUPPLY FOUNDATION
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. TAKEDA PHARMACEUTICAL COMPANY LIMITED
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 12.   Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 13.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11